BridgeMD
Compares treatment options for Distal Hypospadias
Official title Fibrin-Enhanced TIP Versus Grafted TIP Urethroplasty in Distal Hypospadias
ClinicalTrials.gov ID: NCT07319780
What this study is testing
- What it's testing
- Hypospadias is a common congenital condition in boys in which the opening of the urethra is located on the underside of the penis. Distal hypospadias is the most common form and is usually treated surgically using tubularized incised plate (TIP) urethroplasty.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 84, men only
You may be able to join if
- Male children aged 6 months to 84 months
- Primary or redo distal hypospadias
- Unfavorable urethral plate
- Penile curvature less than 45 degrees after degloving
- Eligibility for tubularized incised plate urethroplasty
You likely can't join if
- Disorders of sex development or ambiguous genitalia
- Severe penile curvature requiring urethral plate transection
- Previous graft-based urethroplasty
- Active local or systemic infection at the time of surgery
- Known bleeding or platelet disorders
- Inability to comply with postoperative follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta, DKI Jakarta, Indonesia
- Tashkent, Tashkent, Uzbekistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 6 months to 84 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta, DKI Jakarta, Indonesia; Tashkent, Tashkent, Uzbekistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.